Financial Data and Key Metrics Changes - The company ended the first quarter with a cash balance of $5.8 million, down from $6.4 million at the fiscal year-end [3] - Accounts receivable totaled $4.4 million, slightly down from $4.6 million [3] - Inventory increased to $15 million from $14.3 million, reflecting ramped-up production for the XM30 program [3] - Operating cash uses during the quarter were $0.1 million compared to an operating cash generation of $2.8 million in the prior year [5] - Revenue for the first quarter increased 11.6% year-over-year to $9.1 million [6] - Net income totaled $0.2 million, with adjusted EBITDA at $0.7 million [9] Business Line Data and Key Metrics Changes - Optex-Richardson revenue rose 55.9%, driven by higher periscope production and increased XM30 activity [6] - Applied Optics Center (AOC) revenue declined 20.1%, primarily due to lower laser filter and optical assembly volumes [6] - New orders for the quarter totaled $7.9 million, a 31.7% increase year-over-year, with Optex-Richardson orders rising 46.2% [9] Market Data and Key Metrics Changes - Backlog totaled $37.9 million, down from $42 million last year, primarily due to program delays from the 2025 government shutdown [9] - AOC revenues are expected to improve in the second half of fiscal year 2026, supported by recent bookings and anticipated contract awards [7] Company Strategy and Development Direction - The company is focused on expanding capacity, developing new capabilities, and enhancing research and rapid prototyping [5][6] - Investments in capital improvements are expected to total approximately $2.4 million during fiscal year 2026 [5] - The company aims to broaden its addressable market and create additional revenue streams through new product lines [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to deliver sustainable growth and improving profitability [14] - The current backlog reflects stronger pricing and higher value programs, providing visibility into continued growth [13] - The company anticipates EBITDA improvement as margins recover and revenues increase [9] Other Important Information - The board approved a new stock repurchase program authorizing up to $10 million in common stock purchases [10] - The company has invested in additional machining and assembly equipment to support the XM30 vehicle program [12] Q&A Session Summary - No questions were received during the Q&A session, indicating a lack of immediate inquiries from participants [15]

Financial Data and Key Metrics Changes - Gross profit improved to 29.2% in fiscal year 2025 compared to 28% in the prior fiscal year, driven by higher revenue and favorable manufacturing overhead rates [2] - Operating income increased by $2.3 million, or 47.9%, to $7.1 million in fiscal year 2025 from $4.8 million in fiscal year 2024 [3] - Net income applicable to common shareholders rose to $5.1 million in fiscal year 2025 from $3.8 million in fiscal year 2024, an increase of $1.3 million [3] - Adjusted EBITDA increased by $2.3 million to $8 million during the 12 months ended September 28, 2025, compared to $5.7 million in the prior year [4] Business Line Data and Key Metrics Changes - The company booked $36.2 million in new orders during the 12 months ended September 28, 2025, a 0.5% decrease from $36.4 million in the prior year [4] - Backlog as of September 28, 2025, was $39.1 million, down from $44.2 million as of September 29, 2024 [4] Market Data and Key Metrics Changes - Reduced demand attributed to delays in government contracts, including ARC3 Abrams replenishment contracts and the BNVG Night Vision Goggle program, impacting orders in the last three months of fiscal year 2025 [5] Company Strategy and Development Direction - The company aims to continue double-digit growth while exploring new opportunities, including the production of the Lightweight Transit and driver periscope assembly for the XM30 [11] - A strategic review identified key personnel and equipment to enhance product capabilities in reticles, coatings, and optical assembly [10] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about resolving government funding issues by the end of January 2026, despite current uncertainties [5] - The transition of leadership from Danny Schoening to Chad George was described as well-planned, with a focus on maintaining business performance [12][16] Other Important Information - Danny Schoening resigned as CEO, with Chad George appointed as his successor effective December 20, 2025, while Schoening remains as Chairman of the Board [6][7] Q&A Session Summary Question: Concerns about the transition period following the CEO's departure - Management clarified that the transition was planned over several months, ensuring a smooth handover of responsibilities [15][16]

Financial Data and Key Metrics Changes - The gross profit improved to 29.2% in fiscal year 2025 compared to 28% in the prior fiscal year, attributed to higher revenue and favorable manufacturing overhead rates [2] - Operating income increased by $2.3 million, or 47.9%, to $7.1 million for the year ended September 28, 2025, compared to $4.8 million in the previous year [3] - Net income applicable to common shareholders rose to $5.1 million from $3.8 million, an increase of $1.3 million, primarily due to increased operating income [3] - Adjusted EBITDA increased by $2.3 million to $8 million during the 12 months ended September 28, 2025, compared to $5.7 million in the prior year [4] Business Line Data and Key Metrics Changes - The company booked $36.2 million in new orders during the 12 months ended September 28, 2025, a 0.5% decrease from $36.4 million in the prior year [4] - Backlog as of September 28, 2025, was $39.1 million, down from $44.2 million as of September 29, 2024 [4] Market Data and Key Metrics Changes - A portion of the reduced demand is attributed to delays in government contracts, including the ARC3 Abrams replenishment contracts and the BNVG Night Vision Goggle program, which were expected during fiscal year 2025 [5] - The delay in passing the annual congressional appropriations bill has negatively impacted orders during the last three months of fiscal year 2025 [5] Company Strategy and Development Direction - The company aims to continue its growth trajectory with plans for double-digit growth while exploring new opportunities [11] - The strategic review identified key personnel and equipment to enhance product capabilities in reticles, coatings, and optical assembly [10] - The company is set to start production of new products, including the Lightweight Transit and driver periscope assembly for the XM30 [11] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about resolving government funding issues by the end of January 2026, despite current uncertainties [5] - The transition of leadership from Danny Schoening to Chad George was described as well-planned, with a focus on maintaining business continuity and performance [12][17] Other Important Information - Danny Schoening resigned as CEO, with Chad George appointed as his successor effective December 20, 2025 [6] - The board increased the total number of board seats from four to five following the leadership transition [6] Q&A Session Summary Question: Concerns about the transition period following the CEO's departure - Management clarified that the transition was planned over several months, ensuring a smooth handover of responsibilities [16][17]